Another Step Towards Cannabis-Based Cancer Medications

Antitumor Cannabinoid Chemotypes – Structural Insights

In Summary

A recent study has classified the structural identities of cannabinoids that have shown promise as antitumor agents for a variety of cancer types. Although cannabis is commonly recommended for treating the side-effects associated with chemotherapy researchers are now digging into studies from the past two decades that show cannabis’ promising antitumor properties. Further research is encouraged but the authors hope this structural classification aids future endeavors aiming to develop cannabis-based cancer treatments. 

The idea of accidentally stumbling upon the antitumor and antiproliferative effects of cannabis highlights the unknown therapeutic use of cannabis. Cannabis is full of chemicals that can be used to treat various ailments, such as cannabinoids, terpenes, and flavonoids. Critics often preach against the uncertainty and the danger of tetrahydrocannabinol (THC) but if researchers saw the potential for the other, nonpsychoactive components of cannabis many novel treatments could be developed. The endocannabinoid system spreads throughout the entire body and provides a promising target for numerous ailments if we keep looking into cannabis-based medicine and stumbling upon new therapeutic benefits. 

The study is available for review or download here:

View more studies like this in the CED Foundation Archive 

To explore related information, click the keywords below:

Benjamin Caplan, MDAnother Step Towards Cannabis-Based Cancer Medications